RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Yunnan Baiyao Group Co - Stock

Yunnan Baiyao Group Co Equity 2024

Yunnan Baiyao Group Co Equity

39.88 B CNY

Ticker

000538.SZ

ISIN

CNE0000008X7

WKN

A0M3P2

In 2024, Yunnan Baiyao Group Co's equity was 39.88 B CNY, a 3.57% increase from the 38.5 B CNY equity in the previous year.

Yunnan Baiyao Group Co Aktienanalyse

What does Yunnan Baiyao Group Co do?

Yunnan Baiyao Group Co Ltd is a Chinese company that has been in existence since 1902 and is now one of the most well-known and largest healthcare companies in China. The company is headquartered in the city of Kunming in Yunnan province in southwest China. The company's history began when a Red Cross crusader named Qu Huanzhang from Belgium came to China in 1902. He founded a small herbal medicine clinic in Yunnan to treat local patients. There, he soon developed a herbal medicine called Yunnan Baiyao. As the company grew over the years, it added more products based on traditional Chinese healing methods. Today, Yunnan Baiyao Group Co Ltd is an integrated company specializing in a variety of healthcare fields, from manufacturing medicines to biotechnology. The company's business model is focused on meeting consumers' needs for health and well-being. The company strives to develop and provide high-quality and innovative products and services to ensure that its customers' needs are met. Yunnan Baiyao Group Co Ltd has established itself in various sectors of the healthcare industry. The company's main divisions are pharmaceutical products, biomedical products, health and wellness products, and medical devices. The most well-known product of Yunnan Baiyao Group Co Ltd is Yunnan Baiyao Powder, which is made from over 20 different herbal ingredients. It is traditionally used to treat wounds, injuries, bleeding, and internal organ diseases, and is often prescribed by Chinese doctors. Yunnan Baiyao Group Co Ltd also produces medications for infectious diseases, cardiovascular diseases, cancer, and other illnesses. The company is committed to conducting innovative research and development to ensure the effectiveness and safety of the products it manufactures. In addition to pharmaceutical products, the company also offers biomedical products focusing on the research and development of immunotherapies for the treatment of cancer and other diseases. Yunnan Baiyao Group Co Ltd also has a product portfolio in the health and wellness products sector, including dietary supplements and herbal teas. The company has also developed medical devices, including diagnostic and monitoring devices for intensive care and hospital care. In recent years, Yunnan Baiyao Group Co Ltd has focused heavily on international expansion and now has branches in the United States, Europe, and Hong Kong. It has also formed partnerships with international healthcare companies to strengthen its presence in global markets. Overall, Yunnan Baiyao Group Co Ltd has established itself as a leading healthcare company in China based on traditional Chinese healing methods while also conducting innovative scientific research and development. The company is committed to providing high-quality products and services to improve the health and well-being of its customers. Yunnan Baiyao Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Yunnan Baiyao Group Co's Equity

Yunnan Baiyao Group Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Yunnan Baiyao Group Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Yunnan Baiyao Group Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Yunnan Baiyao Group Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Yunnan Baiyao Group Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Yunnan Baiyao Group Co Stock

What is the equity of Yunnan Baiyao Group Co this year?

Yunnan Baiyao Group Co has equity of 39.88 B CNY this year.

What was the equity of Yunnan Baiyao Group Co compared to the previous year?

The equity of Yunnan Baiyao Group Co has increased/decreased by 3.57% increased compared to the previous year.

What impact does a high equity have on investors of Yunnan Baiyao Group Co?

A high equity is advantageous for investors of Yunnan Baiyao Group Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Yunnan Baiyao Group Co?

A low equity can be a risk for investors of Yunnan Baiyao Group Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Yunnan Baiyao Group Co affect the company?

An increase in equity of Yunnan Baiyao Group Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Yunnan Baiyao Group Co affect the company?

A reduction in equity of Yunnan Baiyao Group Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Yunnan Baiyao Group Co?

Some factors that can affect the equity of Yunnan Baiyao Group Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Yunnan Baiyao Group Co so important for investors?

The equity of Yunnan Baiyao Group Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Yunnan Baiyao Group Co take to change the equity?

To change equity, Yunnan Baiyao Group Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Yunnan Baiyao Group Co pay?

Over the past 12 months, Yunnan Baiyao Group Co paid a dividend of 1.52 CNY . This corresponds to a dividend yield of about 2.97 %. For the coming 12 months, Yunnan Baiyao Group Co is expected to pay a dividend of 1.53 CNY.

What is the dividend yield of Yunnan Baiyao Group Co?

The current dividend yield of Yunnan Baiyao Group Co is 2.97 %.

When does Yunnan Baiyao Group Co pay dividends?

Yunnan Baiyao Group Co pays a quarterly dividend. This is distributed in the months of July, June, June, June.

How secure is the dividend of Yunnan Baiyao Group Co?

Yunnan Baiyao Group Co paid dividends every year for the past 23 years.

What is the dividend of Yunnan Baiyao Group Co?

For the upcoming 12 months, dividends amounting to 1.53 CNY are expected. This corresponds to a dividend yield of 2.99 %.

In which sector is Yunnan Baiyao Group Co located?

Yunnan Baiyao Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Yunnan Baiyao Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Yunnan Baiyao Group Co from 5/10/2024 amounting to 2.077 CNY, you needed to have the stock in your portfolio before the ex-date on 5/10/2024.

When did Yunnan Baiyao Group Co pay the last dividend?

The last dividend was paid out on 5/10/2024.

What was the dividend of Yunnan Baiyao Group Co in the year 2023?

In the year 2023, Yunnan Baiyao Group Co distributed 1.143 CNY as dividends.

In which currency does Yunnan Baiyao Group Co pay out the dividend?

The dividends of Yunnan Baiyao Group Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Yunnan Baiyao Group Co

Our stock analysis for Yunnan Baiyao Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Yunnan Baiyao Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.